Fetal cystoscopy for severe lower urinary tract obstruction - Initial experience of a single center

Rodrigo Ruano, Sergio Duarte, Victor Bunduki, Amilcar Martins Giron, Miguel Srougi, Marcelo Zugaib

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: To report the experience with fetal cystoscopy and laser fulguration of posterior urethral values (PUV) for severe lower urinary tract obstruction (LUTO). Methods: Between July 2006 and December 2008, fetal cystoscopy was offered to 23 patients whose fetuses presented with severe LUTO, favorable urinary analysis and gestational age <26 weeks. Fetal urinary biochemistry was evaluated before and after cystoscopy. All infants were followed 6-12 months after birth. Abnormal renal function was defined when serum creatinine higher than 50 μmol/L (2 Standard Deviation) or the necessity of dialysis or renal transplantation. Autopsy was always performed whenever fetal or neonatal deaths occurred. Results: Eleven patients decided to undergo fetal therapy and 12 elected to continue with expectant observation. There was no difference between both groups in gestation age at diagnosis and referral examinations. Urethral atresia was diagnosed in 4/11 (36.4%) fetuses by fetal cystoscopy. At 26 weeks, fetuses that were managed expectantly presented with worse urinary biochemistry results (p < 0.05). Survival rates and percentage of infants with normal renal function were significantly higher in the cystoscopic group than in the expectant group (p < 0.05). Conclusions: Percutaneous fetal cystoscopy is feasible using a thinner special cannula for prenatal diagnosis and therapy of LUTO. Prenatal laser ablation of the PUV under cystoscopy may prevent renal function deterioration improving postnatal outcome.

Original languageEnglish (US)
Pages (from-to)30-39
Number of pages10
JournalPrenatal Diagnosis
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Cystoscopy
Urinary Tract
Fetus
Kidney
Biochemistry
Fetal Therapies
Fetal Death
Laser Therapy
Prenatal Diagnosis
Kidney Transplantation
Gestational Age
Dialysis
Autopsy
Creatinine
Lasers
Referral and Consultation
Survival Rate
Observation
Parturition
Pregnancy

Keywords

  • Cystoscopy
  • Fetal lower urinary tract obstruction
  • Fetal surgery
  • Lasertherapy
  • Posterior urethral valves

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Genetics(clinical)

Cite this

Fetal cystoscopy for severe lower urinary tract obstruction - Initial experience of a single center. / Ruano, Rodrigo; Duarte, Sergio; Bunduki, Victor; Giron, Amilcar Martins; Srougi, Miguel; Zugaib, Marcelo.

In: Prenatal Diagnosis, Vol. 30, No. 1, 01.01.2010, p. 30-39.

Research output: Contribution to journalArticle

Ruano, Rodrigo ; Duarte, Sergio ; Bunduki, Victor ; Giron, Amilcar Martins ; Srougi, Miguel ; Zugaib, Marcelo. / Fetal cystoscopy for severe lower urinary tract obstruction - Initial experience of a single center. In: Prenatal Diagnosis. 2010 ; Vol. 30, No. 1. pp. 30-39.
@article{645298280fed4a659a71c10f09ff677c,
title = "Fetal cystoscopy for severe lower urinary tract obstruction - Initial experience of a single center",
abstract = "Objective: To report the experience with fetal cystoscopy and laser fulguration of posterior urethral values (PUV) for severe lower urinary tract obstruction (LUTO). Methods: Between July 2006 and December 2008, fetal cystoscopy was offered to 23 patients whose fetuses presented with severe LUTO, favorable urinary analysis and gestational age <26 weeks. Fetal urinary biochemistry was evaluated before and after cystoscopy. All infants were followed 6-12 months after birth. Abnormal renal function was defined when serum creatinine higher than 50 μmol/L (2 Standard Deviation) or the necessity of dialysis or renal transplantation. Autopsy was always performed whenever fetal or neonatal deaths occurred. Results: Eleven patients decided to undergo fetal therapy and 12 elected to continue with expectant observation. There was no difference between both groups in gestation age at diagnosis and referral examinations. Urethral atresia was diagnosed in 4/11 (36.4{\%}) fetuses by fetal cystoscopy. At 26 weeks, fetuses that were managed expectantly presented with worse urinary biochemistry results (p < 0.05). Survival rates and percentage of infants with normal renal function were significantly higher in the cystoscopic group than in the expectant group (p < 0.05). Conclusions: Percutaneous fetal cystoscopy is feasible using a thinner special cannula for prenatal diagnosis and therapy of LUTO. Prenatal laser ablation of the PUV under cystoscopy may prevent renal function deterioration improving postnatal outcome.",
keywords = "Cystoscopy, Fetal lower urinary tract obstruction, Fetal surgery, Lasertherapy, Posterior urethral valves",
author = "Rodrigo Ruano and Sergio Duarte and Victor Bunduki and Giron, {Amilcar Martins} and Miguel Srougi and Marcelo Zugaib",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/pd.2418",
language = "English (US)",
volume = "30",
pages = "30--39",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Fetal cystoscopy for severe lower urinary tract obstruction - Initial experience of a single center

AU - Ruano, Rodrigo

AU - Duarte, Sergio

AU - Bunduki, Victor

AU - Giron, Amilcar Martins

AU - Srougi, Miguel

AU - Zugaib, Marcelo

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Objective: To report the experience with fetal cystoscopy and laser fulguration of posterior urethral values (PUV) for severe lower urinary tract obstruction (LUTO). Methods: Between July 2006 and December 2008, fetal cystoscopy was offered to 23 patients whose fetuses presented with severe LUTO, favorable urinary analysis and gestational age <26 weeks. Fetal urinary biochemistry was evaluated before and after cystoscopy. All infants were followed 6-12 months after birth. Abnormal renal function was defined when serum creatinine higher than 50 μmol/L (2 Standard Deviation) or the necessity of dialysis or renal transplantation. Autopsy was always performed whenever fetal or neonatal deaths occurred. Results: Eleven patients decided to undergo fetal therapy and 12 elected to continue with expectant observation. There was no difference between both groups in gestation age at diagnosis and referral examinations. Urethral atresia was diagnosed in 4/11 (36.4%) fetuses by fetal cystoscopy. At 26 weeks, fetuses that were managed expectantly presented with worse urinary biochemistry results (p < 0.05). Survival rates and percentage of infants with normal renal function were significantly higher in the cystoscopic group than in the expectant group (p < 0.05). Conclusions: Percutaneous fetal cystoscopy is feasible using a thinner special cannula for prenatal diagnosis and therapy of LUTO. Prenatal laser ablation of the PUV under cystoscopy may prevent renal function deterioration improving postnatal outcome.

AB - Objective: To report the experience with fetal cystoscopy and laser fulguration of posterior urethral values (PUV) for severe lower urinary tract obstruction (LUTO). Methods: Between July 2006 and December 2008, fetal cystoscopy was offered to 23 patients whose fetuses presented with severe LUTO, favorable urinary analysis and gestational age <26 weeks. Fetal urinary biochemistry was evaluated before and after cystoscopy. All infants were followed 6-12 months after birth. Abnormal renal function was defined when serum creatinine higher than 50 μmol/L (2 Standard Deviation) or the necessity of dialysis or renal transplantation. Autopsy was always performed whenever fetal or neonatal deaths occurred. Results: Eleven patients decided to undergo fetal therapy and 12 elected to continue with expectant observation. There was no difference between both groups in gestation age at diagnosis and referral examinations. Urethral atresia was diagnosed in 4/11 (36.4%) fetuses by fetal cystoscopy. At 26 weeks, fetuses that were managed expectantly presented with worse urinary biochemistry results (p < 0.05). Survival rates and percentage of infants with normal renal function were significantly higher in the cystoscopic group than in the expectant group (p < 0.05). Conclusions: Percutaneous fetal cystoscopy is feasible using a thinner special cannula for prenatal diagnosis and therapy of LUTO. Prenatal laser ablation of the PUV under cystoscopy may prevent renal function deterioration improving postnatal outcome.

KW - Cystoscopy

KW - Fetal lower urinary tract obstruction

KW - Fetal surgery

KW - Lasertherapy

KW - Posterior urethral valves

UR - http://www.scopus.com/inward/record.url?scp=75149166762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149166762&partnerID=8YFLogxK

U2 - 10.1002/pd.2418

DO - 10.1002/pd.2418

M3 - Article

C2 - 19967749

AN - SCOPUS:75149166762

VL - 30

SP - 30

EP - 39

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 1

ER -